Development
Semler Scientific, Inc.
SMLR
$30.25
-$1.18-3.75%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -7.72% | -12.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.72% | -12.30% | |||
| Cost of Revenue | 204.68% | -8.86% | |||
| Gross Profit | -23.24% | -12.54% | |||
| SG&A Expenses | 9.46% | -15.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.66% | -17.57% | |||
| Operating Income | -61.48% | -3.93% | |||
| Income Before Tax | -59.73% | -8.84% | |||
| Income Tax Expenses | -195.45% | -17.52% | |||
| Earnings from Continuing Operations | -23.45% | -6.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.45% | -6.21% | |||
| EBIT | -61.48% | -3.93% | |||
| EBITDA | -61.21% | -3.71% | |||
| EPS Basic | -24.44% | -6.34% | |||
| Normalized Basic EPS | -56.07% | -2.59% | |||
| EPS Diluted | -24.18% | -5.33% | |||
| Normalized Diluted EPS | -55.02% | -1.83% | |||
| Average Basic Shares Outstanding | 1.31% | 0.15% | |||
| Average Diluted Shares Outstanding | -1.07% | -0.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||